Table 1.
Age | m (sd) | min–max |
63.9 (14.3) | 27–90 | |
Gender | n | % |
Female | 66 | 48.2 |
Male | 71 | 51.8 |
Living situation | n | % |
Living alone | 45 | 32.8 |
Living with others | 92 | 67.2 |
General condition – ECOG | n | % |
0 – fully active | 1 | 0.7 |
1 – restricted in strenuous activity, light work possible | 10 | 7.3 |
2 – ambulatory, capable of self-care, unable to work | 33 | 24.1 |
3 – capable of only limited self-care, 50% confined to bed / chair | 57 | 41.6 |
4 – completely disabled, no self-care, confined to bed / chair | 16 | 11.7 |
5 – dead | 0 | 0.0 |
Missing data | 20 | 14.6 |
Main diagnosis | n | % |
Neoplasm of … | ||
Digestive organs | 24 | 17.5 |
Respiratory/intrathoracic organs | 21 | 15.3 |
Female genital organs | 19 | 13.9 |
Male genital organs | 17 | 12.4 |
Other (< 10% of sample per diagnosis) | 52 | 37.9 |
Non-oncologic | ||
COPD (2x), ALS, heart failure | 4 | 2.9 |
Reason for end of PROM-collection | n | % |
Regular discharge | 92 | 67.2 |
Death | 15 | 10.9 |
Deteriorated health | 21 | 15.3 |
Drop-out – patient decision | 3 | 2.2 |
Drop-out – unknown reason or Covid-19 | 6 | 4.4 |
Abbreviations: m Mean value, sd Standard deviation, min Minimum, max Maximum, n Number of cases, ECOG Eastern Cooperative Oncology Group (ECOG) performance status [25], COPD Chronic Obstructive Pulmonary Disease, ALS Amyotrophic lateral sclerosis, Covid-19 Corona virus disease 19